Horizon Research Group LLC

Coral Gables, Florida 33134

0 studies enrolling now · 2 studies all time

What they study most

End Stage Kidney Disease, Hyperkalemia

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• A Study Evaluating the Safety and Efficacy of RDX013 for the Treatment of Hyperkalemia — Completed